# SBRT-LATTICE-PATHY

> **NCT07645261** · PHASE2 · RECRUITING · sponsor: **University of Sao Paulo General Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Cancer (Advanced Stage)
- Cancer (Solid Tumors)
- Tumor

## Interventions

- **RADIATION:** SBRT-LATTICE-PATHY

## Key facts

- **NCT ID:** NCT07645261
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-28
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07645261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07645261, "SBRT-LATTICE-PATHY". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07645261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*